COMMUNIQUÉS West-GlobeNewswire

Cingulate to Participate in Benzinga All Live Access Event
27/08/2024
KANSAS CITY, Kan., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and [...]
Psyence Biomed to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024
27/08/2024
NEW YORK, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company”), a developer of nature-derived psilocybin-based therapeutics, today announced that it will present [...]
Health Catalyst to Participate in Upcoming Investor Conferences
27/08/2024
SALT LAKE CITY, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced [...]
Fulcrum Therapeutics to Participate in Upcoming September Conferences
27/08/2024
CAMBRIDGE, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc. ® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of [...]
T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
27/08/2024
LEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in [...]
NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences
27/08/2024
MOUNTAIN VIEW, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in [...]
Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule
27/08/2024
WILMETTE, Ill., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage radiopharma company focused on developing innovative treatments for cancer patients, today announced that it [...]
Structure Therapeutics Appoints Angus C. Russell to Board of Directors
27/08/2024
Former Shire CEO brings more than 30 years of experience in building and scaling companies in the global biopharmaceutical industry SAN FRANCISCO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: [...]
LENZ Therapeutics to Participate in Upcoming Investor Conferences
27/08/2024
SAN DIEGO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a late clinical-stage biopharmaceutical company focused on developing the first and only aceclidine-based [...]
Oculis Publishes Consolidated Q2 Financial Statements and MD&A
27/08/2024
ZUG, Switzerland, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Following the Company‘s press release published earlier today, the Q2 Consolidated Financial Statements and the MD&A, which have now been filed with the SEC on [...]
Priority Health, Curai Health partner to offer free virtual health visits to Michigan’s uninsured population
27/08/2024
Leveraging AI to expand access to high-quality care GRAND RAPIDS, Mich., Aug. 27, 2024 (GLOBE NEWSWIRE) -- Priority Health, a nationally recognized nonprofit health plan serving more than 1.3 million members, and Curai [...]
ONWARD® Medical Schedules Webcast to Provide Half-Year 2024 Business Update
27/08/2024
Company to provide more detailed commercial plans for its ARC-EX System EINDHOVEN, The Netherlands, Aug. 27, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating [...]
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
27/08/2024
KUALA LUMPUR, Malaysia, Aug. 27, 2024 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), an emerging leader in genomic diagnostics and personalized medicine, is pleased to announce the successful co-investment [...]
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
27/08/2024
ALK ( ALKB:DC / OMX: ALK B / AKBLF ): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the following transactions [...]
Harvard Apparatus Regenerative Technology Appoints Mao Zhang to Board of Directors
27/08/2024
Holliston, MA, Aug. 27, 2024 (GLOBE NEWSWIRE) -- Harvard Apparatus Regenerative Technology, Inc. (OTCQB: HRGN) (“Harvard Apparatus Regenerative Technology” or the “Company”), a clinical-stage biotechnology company [...]
September Is National Childhood Cancer Awareness Month, but What About 18-24 Year Olds Fighting Cancer?
27/08/2024
The Nikolas Ritschel Foundation Works to Fill the Gap and Grant Wishes to Cancer Patients Between the Ages of 18-24 Who Have Aged Out of Other Childhood Cancer Wish Programs CHICAGO, Aug. 27, 2024 (GLOBE NEWSWIRE) -- As [...]
Novonesis delivers strong half-year results and increases full-year outlook
27/08/2024
In the first half of 2024, Novonesis delivered 7% organic sales growth with an adjusted EBITDA margin at 35.3%. Following strong first half-year performance, Novonesis increases its full-year organic sales outlook from [...]
Interim Report H1 2024
27/08/2024
H1 organic pro forma sales growth at 7%, with pro forma adjusted EBITDA margin at 35.3%. Full-year outlook increased. H1 organic pro forma sales growth of 7% and 8% on IFRS reported basis. Q2 organic pro forma sales [...]
Novonesis increases outlook for full year 2024
27/08/2024
Novonesis increases its full-year sales and profitability outlook based on the first half year performance coupled with strong momentum going into the first months of the second half. The 2024 outlook is increased to [...]

Pages